- 1401. Lipoblast
- [A connective tissue cell that develops into a fat cell. ( NCI )] (UMLS (NCI) C0225320) =Cell
| - 1451. LIPSTICK
- [A waxy solid, usually colored cosmetic, in stick form for the lips. ( NCI )] (UMLS (NCI) C0304638) =Substance ;
|
- 1402. lipodystrophy
- [collection of rare conditions resulting from defective fat metabolism and characterized by atrophy of the subcutaneous fat; includes total, congenital or acquired, partial, abdominal infantile, and localized lipodystrophy. ( CSP )] (UMLS (CSP) C0023787) =Disease or Syndrome =Skin Diseases, Metabolic;
Alteracoes do metabolismo lipidico =Diabetes Mellitus, Lipoatrophic;
| - 1452. liquid
- [A substance in the fluid state of matter having no fixed shape but a fixed volume. ( NCI )] (UMLS (CSP) C0302908) =Substance
|
- 1403. lipofuscin
- [naturally occurring lipid pigment with histochemical characteristics similar to ceroid; it accumulates in various normal tissues and apparently increases in quantity with age. ( CSP )] (UMLS (CSP) C0023789) =Lipid; Biologically Active Substance ;
=lipid;
pigment | - 1453. liquid
- [A strictly liquid diet, that can be fully absorbed in the intestine, and therefore may not contain fiber. Used before enteral surgeries. ( HL7V3.0 )] (UMLS (HL7) C1550563) =Intellectual Product =Diet;
|
- 1404. lipogenesis inhibitor
- [any substance or agent which suppresses, prevents or opposes the biosynthesis of lipids in organisms or living cells. ( CSP )] (UMLS (CSP) C0596847) =Chemical Viewed Functionally =inhibitor/antagonist;
| - 1454. liquid chromatography mass spectroscopy
- [ ] (UMLS (CSP) C0920568) =Laboratory Procedure
|
- 1405. lipoid histiocytosis (classical phosphatide)
- [caused by deficiency of sphingomyelinase, resulting in accumulation of sphingomyelin in the reticuloendothelial system, mental and physical retardation, enlarged liver and spleen, anemia, and blindness. ( CSP )] (UMLS (CSP) C0028064) =Disease or Syndrome =Histiocytosis, Non-Langerhans-Cell;
Sphingolipidoses;
enzyme deficiency;
| - 1455. liquid crystal
- [thermodynamic stable phase characterized by anisotropy of properties without the existence of a three-dimensional crystal lattice, generally lying in the temperature range between the solid and isotropic liquid phase. ( CSP )] (UMLS (CSP) C0302603) =Chemical Viewed Structurally =physical state;
|
- 1406. LIPOID METABOL DIS NEC
- [ ] (UMLS (ICD9CM) C0029591) =Disease or Syndrome
| - 1456. liquid dynamics
- [ ] (UMLS (CSP) C0598444) =Quantitative Concept
|
- 1407. lipolysis
- [decomposition or splitting up of fats or lipids. ( CSP )] (UMLS (CSP) C0023796) =Organism Function =fat metabolism;
| - 1457. liquid hybridization
- [hybridization of two single-stranded nucleic acids when both are in solution, suitable when both are free of their original duplex complementary strand; used to assay complementarity and to monitor renaturation kinetics. ( CSP )] (UMLS (CSP) C0599442) =Molecular Biology Research Technique ;
=Hybridization;
|
- 1408. Lipoma
- [A benign, usually painless, well-circumscribed lipomatous tumor composed of adipose tissue.(NCI)] (UMLS (ICPC) C0023798) (Lipoma; AZALEKO LIPOMA; Lipom; Lipoom; LIPOOMA, RASVAKASVAIN; Lipome; Lipom; lipoma baor; lipoma; Lipoma; LIPOM; Lipoma; Lipoma; LIPOM) =Neoplastic Process =Adipose Tissue Neoplasm; Diagnosis/Diseases Component; Integument;
| - 1458. Liquid nitrogen
- (UMLS (HL7) C1550121) =Intellectual Product =Special Handling Code;
|
- 1409. LIPOMA INTRA-ABDOMINAL
- [ ] (UMLS (ICD9CM) C0153971) =Neoplastic Process
| - 1459. Liquid NOS
- (UMLS (HL7) C1546699) =Intellectual Product =Specimen Source Codes;
|
- 1410. LIPOMA INTRATHORACIC
- [ ] (UMLS (ICD9CM) C0153970) =Neoplastic Process
| - 1460. Liquid NOS
- (UMLS (HL7) C1561501) =Substance =SpecimenEntityType;
|
- 1411. LIPOMA NEC
- (UMLS (ICD9CM) C0023800) =Neoplastic Process
| - 1461. Liquid Pred
- (UMLS (NCI) C0728769) =Steroid; Pharmacologic Substance
|
- 1412. Lipoma of Mediastinum
- [A benign adipose tissue neoplasm of the anterior, middle or posterior mediastinum. ( NCI )] (UMLS (NCI) C1334661) Lipoma of the Mediastinum;
Mediastinal Lipoma;
=Neoplastic Process | - 1462. Liquid Stool
- (UMLS (HL7) C1550307) =Body Substance =Body Part;
|
- 1413. Lipoma of Mouth
- [A benign adipose tissue neoplasm of the oral cavity. It usually occurs within the lingual and buccal mucosa. ( NCI )] (UMLS (NCI) C1335120) Lipoma of Oral Cavity;
Lipoma of the Mouth;
Lipoma of the Oral Cavity;
Mouth Lipoma;
Oral Cavity Lipoma =Neoplastic Process ;
| - 1463. Liquid Waste
- (UMLS (HL7) C1550144) =Substance =Substance type;
|
- 1414. Lipoma of other skin and subcutaneous tissue
- [ ] (UMLS (ICD9CM) C0153969) =Neoplastic Process
| - 1464. Liquid, Other
- (UMLS (HL7) C1546700) =Intellectual Product =Specimen Source Codes;
|
- 1415. Lipoma of Parotid
- [A rare benign adipose tissue neoplasm of the major salivary gland. It predominantly occurs in males. ( NCI )] (UMLS (NCI) C1335360) Lipoma of Parotid Gland;
Lipoma of the Parotid;
Lipoma of the Parotid Gland;
Parotid Gland Lipoma;
Parotid Lipoma =Neoplastic Process ;
| - 1465. LiquidLiquidEmulsion
- [A two-phase system in which one liquid is dispersed throughout another liquid in the form of small droplets. ( HL7V3.0 )] (UMLS (HL7) C1698849) =Chemical Viewed Structurally; Pharmacologic Substance =DispensableDrugForm;
=OINTMENT;
LOTION;
CREAM |
- 1416. Lipoma of Pleura
- [A benign adipose tissue neoplasm of the pleural cavity. It may be purely intra-thoracic or extend to the chest wall. ( NCI )] (UMLS (NCI) C1335434) Lipoma of the Pleura;
Pleural Lipoma;
=Neoplastic Process ;
| - 1466. LiquidSolidSuspension
- [A liquid preparation which consists of solid particles dispersed throughout a liquid phase in which the particles are not soluble. ( HL7V3.0 )] (UMLS (HL7) C1698850) =Chemical Viewed Structurally; Pharmacologic Substance =DispensableDrugForm;
=GEL;
SUSP;
PASTE |
- 1417. Lipoma of Rectum
- [A benign adipose tissue neoplasm of the rectum. ( NCI )] (UMLS (NCI) C1335684) Lipoma of the Rectum;
Rectal Lipoma =Neoplastic Process ;
| - 1467. Liquor
- [An alcoholic beverage in which the initial fermentation mixture is distilled in order to concentrate the alcohol, generally resulting in a mixture that is at least 35% alcohol by volume. ( NCI )] (UMLS (NCI) C0301611) =Food
|
- 1418. Lipoma of skin and subcutaneous tissue of face
- [ ] (UMLS (ICD9CM) C0153968) =Neoplastic Process
| - 1468. Lira
- [Lira, monetary currency of Turkey ( HL7V3.0 )] (UMLS (HL7) C1555441) =Quantitative Concept =Currency;
|
- 1419. Lipoma of Small Bowel
- [A rare benign adipose tissue neoplasm of the small intestine. It usually arises from the submucosa and occasionally protrudes into the lumen. ( NCI )] (UMLS (NCI) C1336001) Lipoma of Small Intestine;
Lipoma of the Small Bowel;
Lipoma of the Small Intestine;
Small Bowel Lipoma;
Small Intestinal Lipoma =Neoplastic Process | - 1469. Liranaftate
- (UMLS (NCI) C1173390) =Organic Chemical; ;
|
- 1420. Lipoma of Spermatic Cord
- [A benign adipose tissue neoplasm of the spermatic cord. This is the most common tumor amongst the benign paratesticular lesions. ( NCI )] (UMLS (NCI) C0153972) =Neoplastic Process
| - 1470. Liriope tetraphylla
- [A species of hydrozoan sea organism, not to be confused with LIRIOPE PLANT. ( MSH )] (UMLS (CSP) C1006914) =Invertebrate
|
- 1421. Lipoma of Spinal Cord
- [A benign adipose tissue neoplasm of the spinal cord. It is usually associated with dysraphism in which the intraspinal component communicates with a subcutaneous lipoma through a defect in the posterior elements of the spine. Non-dysraphic intramedullary spinal cord lipomas are very rare. ( NCI )] (UMLS (NCI) C0347446) =Neoplastic Process
| - 1471. Liroldine
- (UMLS (NCI) C0671076) =Organic Chemical; Pharmacologic Substance
|
- 1422. Lipoma of Tendon Sheath
- [A benign tumor, composed of mature adipocytes, that arises within the tendon sheath. ( NCI )] (UMLS (NCI) C1336703) Lipoma of the Tendon Sheath;
Tendon Sheath Lipoma;
=Neoplastic Process ;
| - 1472. Lisacort
- (UMLS (NCI) C0740149) =Steroid; Pharmacologic Substance; Hormone
|
- 1423. Lipoma of the Tongue
- [A benign adipose tissue neoplasm of the tongue. ( NCI )] (UMLS (NCI) C0238467) =Neoplastic Process
| - 1473. LISINOPRIL
- [lysine derivative of the active form of enalapril; an angiotensin converting enzyme inhibitor used in the treatment of hypertension. ( CSP )] (UMLS (NCI) C0065374) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
=[CV800] ACE INHIBITORS;
antihypertensive agent;
dipeptide;
=LISINOPRIL 10 MG;
LISINOPRIL 2.5 MG;
LISINOPRIL 20 MG;
LISINOPRIL 30 MG;
LISINOPRIL 40 MG;
LISINOPRIL 5 MG |
- 1424. Lipoma of the Tonsil
- [A benign adipose tissue neoplasm of the tonsils. ( NCI )] (UMLS (NCI) C1336764) Lipoma of Tonsil;
Tonsil Lipoma;
Tonsillar Lipoma;
=Neoplastic Process ;
| - 1474. Lisofylline
- [A drug that may protect healthy cells from chemotherapy and radiation without inhibiting the effects of these therapies on tumor cells. ( NCI )] (UMLS (NCI) C0243902) =Organic Chemical; Pharmacologic Substance ;
|
- 1425. Lipomatous Hamartoma
- (UMLS (NCI) C1302836) =Disease or Syndrome
| - 1475. LISP artificial intelligence language
- [ ] (UMLS (CSP) C0597914) =Language ;
|
- 1426. Lipomatous Hemangiopericytoma
- [A benign hemangiopericytoma with lipomatous differentiation. ( NCI )] (UMLS (NCI) C1334402) =Neoplastic Process; ;
| - 1476. List
- [A series of names, words, or other items written, printed, or imagined one after the other. ( NCI )] (UMLS (NCI) C0745732) =Conceptual Entity ;
|
- 1427. lipomucopolysaccharidosis
- [ ] (UMLS (CSP) C0023806) =Disease or Syndrome
| - 1477. List Style
- [Defines list rendering characteristics ( HL7V3.0 )] (UMLS (HL7) C1701429) =Functional Concept ;
=StyleType;
=Unordered List Style;
Ordered List Style;
|
- 1428. lipooligosaccharide
- [ ] (UMLS (CSP) C0065036) =Carbohydrate; Lipid ;
| - 1478. Listeria
- [genus of bacteria which may be found in the feces of animals and man, on vegetation, and in silage; parasitic on cold blooded and warm blooded animals, including man. ( CSP )] (UMLS (CSP) C0023859) =Bacterium =gram positive bacteria;
coryneform bacteria |
- 1429. lipophilicity
- [Lipophilicity represents the affinity of a molecule or a moiety for a lipophilic environment. It is commonly measured by its distribution behavior in a biphasic system, either liquid-liquid or solid-liquid, or thin-layer chromatography system. (from Pure Appl. Chem., 70, 1129-1143 (1998)) ( NCI )] (UMLS (CSP) C0598631) =Quantitative Concept ;
| - 1479. Listeria infection
- [gram positive bacterial infection with the genus Listeria including Listeria meningitis which causes clinical manifestations including fever, altered mentation, headache, meningeal signs, focal neurologic signs, and seizures. ( CSP )] (UMLS (CSP) C0023860) =Disease or Syndrome =bacterial disease;
Gram-Positive Bacterial Infections =Meningitis, Listeria;
|
- 1430. lipophobicity
- [ ] (UMLS (CSP) C0598632) =Quantitative Concept ;
| - 1480. listeriolysin
- [ ] (UMLS (CSP) C0065082) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
|
- 1431. lipopolysaccharide
- [lipid-containing polysaccharides which are endotoxins and important group-specific antigens; often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. ( CSP )] (UMLS (CSP) C0023810) =Lipid =Mitogen;
bacterial polysaccharide | - 1481. Litalir
- (UMLS (NCI) C0729130) =Organic Chemical; Pharmacologic Substance
|
- 1432. Lipopolysaccharide Biosynthesis
- [The chemical reactions and pathways resulting in the formation of lipopolysaccharides, any of a group of related, structurally complex components of the outer membrane of Gram-negative bacteria. [GOC:ai] ( GO )] (UMLS (NCI) C1157209) Lipopolysaccharide Biosynthesis Pathway;
=Molecular Function | - 1482. literacy
- [The ability to read and write. ( NCI )] (UMLS (CSP) C0023864) =Functional Concept
|
- 1433. Lipoprotein
- [An important class of serum proteins in which a spherical hydrophobic core of triglycerides or cholesterol esters surrounded by an amphipathic monolayer of phospholipids, cholesterol and apolipoproteins. Classified according to density: chylomicrons, large low density particles, very low density, low density and high density species. Important in lipid transport, especially cholesterol transport in the blood stream. Abnormalities in lipoprotein metabolism have been implicated in certain heart diseases. ( NCI )] (UMLS (NCI) C0023820) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=lipid;
gene product;
Biological Macromolecular Agents;
=Surfactants;
Lung Surfactant | - 1483. literate
- [ ] (UMLS (CSP) C0682193) =Finding
|
- 1434. lipoprotein disorder
- [deviation or interruption in the processing of lipoproteins in the body: its biosynthesis, absorption, transport, storage, and utilization. ( CSP )] (UMLS (CSP) C0596848) =Disease or Syndrome =blood protein disorder;
Alteracoes do metabolismo lipidico =hyperlipoproteinemia;
hypolipoproteinemia;
| - 1484. Literature
- [Writings having excellence of form or expression and expressing ideas of permanent or universal interest. The body of written works produced in a particular language, country, or age. (Webster, 3d ed) ( MSH )] (UMLS (HL7) C0023866) =Intellectual Product =Report source;
|
- 1435. lipoprotein lipase inhibitor
- [ ] (UMLS (CSP) C0598387) =Pharmacologic Substance
| - 1485. Literature
- [copy or copies of a document offered for distribution; includes the preparation of the documented material. ( CSP )] (UMLS (NCI) C0034036) =Manufactured Object; Intellectual Product =information dissemination;
=book;
journal;
literature survey;
monograph;
catalog;
handbook;
literature citation;
|
- 1436. lipoprotein metabolism disorder
- [ ] (UMLS (CSP) C0494345) =Disease or Syndrome
| - 1486. literature citation
- [reference to or quotation from literature. ( CSP )] (UMLS (CSP) C0596849) =Intellectual Product =Literature;
|
- 1437. Liposarcoma
- [malignant tumor derived from primitive or embryonal lipoblastic cells; may be composed of well-differentiated fat cells or may be dedifferentiated: myxoid, round-celled, or pleomorphic, usually in association with a rich network of capillaries; recurrences are common and dedifferentiated liposarcomas metastasize to the lungs or serosal surfaces. ( CSP )] (UMLS (NCI) C0023827) =Neoplastic Process =connective tissue cancer;
Adipose Tissue Neoplasm;
Connective Tissue Sarcoma;
=Liposarcoma, Myxoid;
| - 1487. Literature reports association of product with event
- (UMLS (HL7) C1546999) =Idea or Concept =Causality Observations;
|
- 1438. Liposarcoma Metastatic
- [A liposarcoma that has metastasized to a secondary site. ( NCI )] (UMLS (NCI) C0855059) Metastatic Liposarcoma =Neoplastic Process
| - 1488. literature survey
- [detailed critical inspection of published writings on a particular subject. ( CSP )] (UMLS (CSP) C0178732) =Intellectual Product ;
=Literature;
|
- 1439. Liposarcoma Nonmetastatic
- [A liposarcoma that has not metastasized to secondary sites. ( NCI )] (UMLS (NCI) C0855060) Non-Metastatic Liposarcoma;
Primary Liposarcoma;
=Neoplastic Process | - 1489. Lithane
- (UMLS (NCI) C0700752) =Pharmacologic Substance; Inorganic Chemical
|
- 1440. Liposarcoma of Mediastinum
- [A malignant adipose tissue neoplasm of the anterior, middle or posterior mediastinum. ( NCI )] (UMLS (NCI) C1334663) Liposarcoma of the Mediastinum;
Mediastinal Liposarcoma;
=Neoplastic Process | - 1490. Lithium Carbonate
- (UMLS (HL7) C1548876) =Health Care Activity =Consent Type;
|
- 1441. Liposarcoma of Ovary
- [A malignant adipose tissue neoplasm of the ovary. ( NCI )] (UMLS (NCI) C1335165) Liposarcoma of the Ovary;
Ovarian Liposarcoma;
=Neoplastic Process | - 1491. LITHIUM CARBONATE
- [The carbonate salt of lithium, a monovalent cation with antimanic activity. Lithium carbonate interferes with transmembrane sodium exchange in nerve cells by affecting sodium, potassium-stimulated adenosine triphosphatase (Na+, K+-ATPase); altering the release of neurotransmitters; reducing cyclic adenosine monophosphate (cAMP) concentrations and modulating cAMP second-messenger processes; and suppressing signal transduction pathways through the depletion of intracellular inositol and inhibition of the enzyme, glycogen synthase-kinase-3 (GSK-3). The exact mechanism through which lithium carbonate exerts its mood-stabilizing effect is not fully known. ( NCI )] (UMLS (NCI) C0085217) =Pharmacologic Substance; Inorganic Chemical ;
=carbonate;
Li element;
Lithium Compounds;
=LITHIUM CARBONATE 150 MG;
LITHIUM CARBONATE 600 MG;
LITHIUM CARBONATE 300 MG;
LITHIUM CARBONATE 450 MG;
|
- 1442. Liposarcoma Recurrent
- [The reemergence of a malignant adipose tissue neoplasm after a period of remission. ( NCI )] (UMLS (NCI) C0855061) Recurrent Liposarcoma;
Relapsed Liposarcoma;
=Neoplastic Process | - 1492. LITHIUM CITRATE
- [The citrate salt of lithium, a monovalent cation with antimanic activity. Although the exact mechanism is unclear, lithium might exert its mood-stabilizing effect via reduction of catecholamine concentration mediated through transneuronal membrane transport of sodium ion by sodium-potassium-stimulated adenosine triphosphatase (Na-K-ATPase). Alternatively, lithium may decrease cyclic adenosine monophosphate (cAMP) concentrations, which would desensitize hormonal-sensitive adenylyl cyclase receptors. Furthermore, lithium, in recommended dosage, blocks the activity of inositol-1-phosphatase, thereby resulting in subsequent decrease of postsynaptic second messengers, diacylglycerol and inositol triphosphate, that contribute to chronic cell stimulation by altering electrical activity in the neuron. ( NCI )] (UMLS (NCI) C0125997) =Organic Chemical; Pharmacologic Substance ;
=[TN410] CITRATES;
Li element =lithium citrate 1.6 MEQ/ML |
- 1443. liposomal
- [single or multilaminar vesicles (made from lecithins or other lipids) that can be used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer; also used to study membranes and membrane proteins. ( CSP )] (UMLS (NCI) C0023828) =Cell Component; Lipid ;
=DDS;
membrane | - 1493. Lithium iodoacetate
- (UMLS (HL7) C1550076) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid =Additive/Preservative;
|
- 1444. liposomal lurtotecan
- [A liposome-encapsulated formulation of lurtotecan with antineoplastic activity. Lurtotecan, a semisynthetic analogue of camptothecin, selectively stabilizes the topoisomerase I-DNA covalent complex and forms an enzyme-drug-DNA ternary complex during S phase of the cell cycle, thereby inhibiting religation of topoisomerase I-mediated single-stranded DNA breaks. This ultimately results in an inhibition of DNA replication, inducing double-stranded DNA breakages, obstruction of RNA and protein synthesis and triggering apoptosis. Furthermore, this agent also stimulates degradation of topoisomerase I, likely mediated through ubiquitin-proteasomal pathway. Liposomal delivery of lurtotecan improves its penetration and delivery into tumors while lowering systemic side effects. ( NCI )] (UMLS (NCI) C0796638) liposome, lurtotecan;
Lurtotecan Liposome;
=Organic Chemical; Pharmacologic Substance ;
| - 1494. Lithium iodoacetate
- [Iodoacetate lithium salt ( HL7V3.0 )] (UMLS (HL7) C1561478) =Intellectual Product =MaterialEntityAdditive;
|
- 1445. Liposomal NDDP
- [A synthetic liposomal formulation of bis-neodecanoate diaminocyclohexane platinum (NDDP) with potential antineoplastic activity. Liposomal NDDP is a third-generation antineoplastic platinum complex, an analogue of cisplatin. After displacement of the 2 long-chain aliphatic leaving groups (neodecanoic acid), platinum diaminocyclohexane (DACH) complexes become highly reactive and able to alkylate macromolecules, forming both inter- and intra-strand DNA crosslinkings, thereby inhibiting DNA synthesis and resulting in cytotoxicity. The DACH moiety of this agent appears to inhibit DNA repair mechanism, which overcome the limits observed in other platinum-based therapies. In addition, the liposomal encapsulation improves the bioavailability of NDDP, increases delivery to tumor tissues and reduces its toxicity profile. ( NCI )] (UMLS (NCI) C0125061) =Organic Chemical; Pharmacologic Substance ;
| - 1495. LITHIUM THERAPY
- [ ] (UMLS (ICD9CM) C0204592) =Therapeutic or Preventive Procedure
|
- 1446. Liposome-Encapsulated Paclitaxel
- [A liposome-encapsulated formulation of paclitaxel, a taxoid compound extracted from the Pacific yew tree Taxus brevifolia with antineoplastic property. Paclitaxel binds to tubulin and interferes with the assembly/disassembly dynamics of microtubules, thereby resulting in the inhibition of cell division. This agent also induces apoptosis via inactivation of the apoptosis inhibitor, B-cell Leukemia 2 (Bcl-2) protein. Paclitaxel liposome formulation potentially enhances delivery of higher doses of paclitaxel to the target tissues and exhibits lower systemic toxicity. ( NCI )] (UMLS (NCI) C0935868) Paclitaxel Liposome =Organic Chemical; Pharmacologic Substance
| - 1496. Lithium/Li Heparin
- (UMLS (HL7) C1550072) =Carbohydrate; Indicator, Reagent, or Diagnostic Aid ;
=Additive/Preservative;
|
- 1447. Liposyn
- (UMLS (NCI) C0065066) =Lipid
| - 1497. Lithium/Li Heparin
- [Lithium heparin salt ( HL7V3.0 )] (UMLS (HL7) C1561475) =Intellectual Product =MaterialEntityAdditive;
|
- 1448. Lipothrixviridae
- [Family of enveloped, lipid-containing, filamentous DNA viruses that infect ARCHAEA. ( MSH )] (UMLS (CSP) C0598319) =Virus
| - 1498. Lithobid
- (UMLS (NCI) C0700751) =Pharmacologic Substance; Inorganic Chemical
|
- 1449. lipoxin
- [Trihydroxy derivatives of eicosanoic acids. They are primarily derived from arachidonic acid, however eicosapentaenoic acid derivatives also exist. Many of them are naturally occurring mediators of immune regulation. ( MSH )] (UMLS (CSP) C0599689) =Lipid; Biologically Active Substance
| - 1499. lithocholate
- [ ] (UMLS (CSP) C0086564) =Steroid; Pharmacologic Substance; Biologically Active Substance ;
|
- 1450. lipreading
- [determining what a person is saying by watching the movement of their lips. ( CSP )] (UMLS (CSP) C0023844) =Activity =deaf aid;
| - 1500. lithography
- [ ] (UMLS (CSP) C0599199) =Occupational Activity ;
|
home 
Armenian-English 
top